Clinical Trial Update: Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating docetaxel in combination with PTK787 in metastatic breast cancer and gynecologic cancers; the trial conducted by Dana-Farber Cancer Ins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PTK787 (Vatalanib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 1 | Status: COMPLETED